433 related articles for article (PubMed ID: 11557913)
1. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
[TBL] [Abstract][Full Text] [Related]
2. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil.
Laine K; Kivistö KT; Neuvonen PJ
J Toxicol Clin Toxicol; 1997; 35(3):263-8. PubMed ID: 9140320
[TBL] [Abstract][Full Text] [Related]
3. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal.
Olsen KM; Ma FH; Ackerman BH; Stull RE
Pharmacotherapy; 1993; 13(3):229-32. PubMed ID: 8100628
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
[TBL] [Abstract][Full Text] [Related]
5. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine.
Keränen T; Sorri A; Moilanen E; Ylitalo P
Arzneimittelforschung; 2010; 60(7):421-6. PubMed ID: 20712131
[TBL] [Abstract][Full Text] [Related]
6. Limited efficacy of gastrointestinal decontamination in severe slow-release carbamazepine overdose.
Lurie Y; Bentur Y; Levy Y; Baum E; Krivoy N
Ann Pharmacother; 2007 Sep; 41(9):1539-43. PubMed ID: 17666577
[TBL] [Abstract][Full Text] [Related]
7. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
Eyer F; Jung N; Neuberger H; Witte A; Poethko T; Henke J; Zilker T
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):337-46. PubMed ID: 18248517
[TBL] [Abstract][Full Text] [Related]
8. [Measures to reduce absorption in the treatment of intoxications].
de Vries I; van Zoelen GA; van Riel AJ; Meulenbelt J
Ned Tijdschr Geneeskd; 2005 Dec; 149(53):2964-8. PubMed ID: 16425848
[TBL] [Abstract][Full Text] [Related]
9. Whole-bowel irrigation as adjunctive treatment for sustained-release theophylline overdose.
Burkhart KK; Wuerz RC; Donovan JW
Ann Emerg Med; 1992 Nov; 21(11):1316-20. PubMed ID: 1416325
[TBL] [Abstract][Full Text] [Related]
10. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium.
Buckley N; Dawson AH; Howarth D; Whyte IM
Med J Aust; 1993 Feb; 158(3):202-4. PubMed ID: 8450791
[TBL] [Abstract][Full Text] [Related]
11. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
[TBL] [Abstract][Full Text] [Related]
14. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
15. Effect of activated charcoal in reducing paracetamol absorption at a supra-therapeutic dose.
Wananukul W; Klaikleun S; Sriapha C; Tongpoo A
J Med Assoc Thai; 2010 Oct; 93(10):1145-9. PubMed ID: 20973316
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
Dulac O; Alvarez JC
Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
Levy G; Soda DM; Lampman TA
Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers.
Gude AB; Hoegberg LC; Angelo HR; Christensen HR
Basic Clin Pharmacol Toxicol; 2010 May; 106(5):406-10. PubMed ID: 20002061
[TBL] [Abstract][Full Text] [Related]
19. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
Tompson DJ; Vearer D
Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
[TBL] [Abstract][Full Text] [Related]
20. Multiple-dose charcoal and whole-bowel irrigation do not increase clearance of absorbed salicylate.
Mayer AL; Sitar DS; Tenenbein M
Arch Intern Med; 1992 Feb; 152(2):393-6. PubMed ID: 1739372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
